15 employees
ImmuneBridge is developing allogeneic immunotherapies for cancer.
2018
$12M
from 4 investors over 4 rounds
ImmuneBridge raised $12M on January 9, 2023
Investors: One Way Ventures, M Ventures and Insight Partners
ImmuneBridge raised undisclosed on May 8, 2018
Investors: Quiet Capital